The announcement follows their previous commitment to offering COVID-19 testing at local hospitals.
Pediatricians stress the importance of understanding the effects of COVID-19 on children.
Officials with the FDA have approved a 420-mg multi-dose of trastuzumab-bttb (Ontruzant, Samsung Bioepis), a biosimilar referencing trastuzumab (Herceptin).
Due to the coronavirus disease 2019 (COVID-19) crisis, CVS Health and Walgreens are going on major hiring sprees that are likely to benefit pharmacists and pharmacy technicians.
Due to the increased need for albuterol inhalers in hospitals for COVID-19, shortages have been occurring in some areas of the country and will likely continue to affect supplies.
Increases in PrEP coverage were associated with reductions in HIV infections, a new study found.
Phase 3 clinical data demonstrate abrocitinib’s efficacy and safety in treating moderate-to-severe atopic dermatitis in adults.
The updated labeling recommends temporary discontinuation of SGLT2 inhibitors before scheduled surgery.
The FDA issued emergency use authorization of a rapid, point-of-care COVID-19 diagnostic test, developed by Cepheid, that has a detection time of approximately 45 minutes.
There is currently no scientific evidence suggesting that non-steroidal anti-inflammatory drug use could worsen COVID-19 in those infected.